Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jimmy M-M. Kwok"'
Autor:
Eric W.-F. Lam, Stephen S. Myatt, R. Charles Coombes, Julie Millour, Helma D.C. Schwenen, Lara J. Monteiro, Barrie Peck, Jimmy M.-M. Kwok
Supplementary Data from FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a982c6134ee52906078facde08d639ae
https://doi.org/10.1158/1541-7786.22519287.v1
https://doi.org/10.1158/1541-7786.22519287.v1
Supplementary Fig. S1 from Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Autor:
Eric W-F. Lam, R. Charles Coombes, Andreas Polychronis, Jimmy M-M. Kwok, Janna Krol, Stephen S. Myatt, Jun Wang, Stephanie K. Guest, Barrie Peck, Richard E. Francis, Ursula B. McGovern
Supplementary Fig. S1 from Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86252130ef627516354c6d9b135f58bd
https://doi.org/10.1158/1535-7163.22485026
https://doi.org/10.1158/1535-7163.22485026
Supplementary Fig. S3 from Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Autor:
Eric W-F. Lam, R. Charles Coombes, Andreas Polychronis, Jimmy M-M. Kwok, Janna Krol, Stephen S. Myatt, Jun Wang, Stephanie K. Guest, Barrie Peck, Richard E. Francis, Ursula B. McGovern
Supplementary Fig. S3 from Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0812b2ab66b70e767cf71a4693aad357
https://doi.org/10.1158/1535-7163.22485017
https://doi.org/10.1158/1535-7163.22485017
Autor:
Eric W-F. Lam, R. Charles Coombes, Andreas Polychronis, Jimmy M-M. Kwok, Janna Krol, Stephen S. Myatt, Jun Wang, Stephanie K. Guest, Barrie Peck, Richard E. Francis, Ursula B. McGovern
Gefitinib (Iressa) is a specific and effective epidermal growth factor receptor inhibitor. An understanding of the downstream cellular targets of gefitinib will allow the discovery of biomarkers for predicting outcomes and monitoring anti-epidermal g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c787fc79d949ac7b71cebe55bc44f028
https://doi.org/10.1158/1535-7163.c.6531728
https://doi.org/10.1158/1535-7163.c.6531728
Supplementary Fig. S2 from Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Autor:
Eric W-F. Lam, R. Charles Coombes, Andreas Polychronis, Jimmy M-M. Kwok, Janna Krol, Stephen S. Myatt, Jun Wang, Stephanie K. Guest, Barrie Peck, Richard E. Francis, Ursula B. McGovern
Supplementary Fig. S2 from Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36b44a7579957ff1e3a70308735617bc
https://doi.org/10.1158/1535-7163.22485020.v1
https://doi.org/10.1158/1535-7163.22485020.v1
Autor:
Eric Lam, Barrie Peck, R. Charles Coombes, Julie Millour, Lara J. Monteiro, Stephen S. Myatt, Jimmy M.-M. Kwok, Helma Dc Schwenen
Publikováno v:
Molecular Cancer Research. 8:24-34
The transcription factor Forkhead box M1 (FOXM1) is a key regulator of cell proliferation and is overexpressed in many forms of primary cancers, leading to uncontrolled cell division and genomic instability. To address the role of FOXM1 in chemoresis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8017cbd12f5a6b4ae237ff8b414defbe
https://doi.org/10.1158/1541-7786.mcr-09-0432
https://doi.org/10.1158/1541-7786.mcr-09-0432
Autor:
Ursula B. McGovern, Richard E. Francis, Stephanie K. Guest, Andreas Polychronis, Janna Krol, R. Charles Coombes, Jimmy M.-M. Kwok, Jun Wang, Stephen S. Myatt, Barrie Peck, Eric Lam
Publikováno v:
Molecular Cancer Therapeutics. 8:582-591
Gefitinib (Iressa) is a specific and effective epidermal growth factor receptor inhibitor. An understanding of the downstream cellular targets of gefitinib will allow the discovery of biomarkers for predicting outcomes and monitoring anti-epidermal g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1108568f3875f25d2c49278f1def16bd
https://doi.org/10.1158/1535-7163.mct-08-0805
https://doi.org/10.1158/1535-7163.mct-08-0805
Autor:
Charles M. Marson, Stephen S. Myatt, R. Charles Coombes, Jimmy M.-M. Kwok, Eric Lam, Demetra Constantinidou
Publikováno v:
Molecular cancer therapeutics. 7(7)
Elevated expression or activity of the transcription factor forkhead box M1 (FOXM1) is associated with the development and progression of many malignancies, including breast cancer. In this study, we show that the thiazole antibiotic thiostrepton sel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c480552ac4292550be84475a2b34caed
https://pubmed.ncbi.nlm.nih.gov/18645012
https://pubmed.ncbi.nlm.nih.gov/18645012